Alterity Therapeutics (ATHE) Income from Continuing Operations (2016 - 2019)

Alterity Therapeutics' Income from Continuing Operations history runs 4 years deep, the most recent figure standing at 3853361.65 for Q4 2019.

• In Q4 2019, Income from Continuing Operations fell 0.58% year-over-year to 3853361.65; the TTM figure through Dec 2019 stood at 13205834.23 (changed N/A YoY), while the FY2025 annual figure was 7779872.4, up 38.27% from the prior year.
• Income from Continuing Operations was 3853361.65 for Q4 2019 at Alterity Therapeutics, down from 3831060.31 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 2739462.19 in Q4 2016 to a low of 3853361.65 in Q4 2019.
• Historically, Income from Continuing Operations has averaged 3301458.56 across 4 years, with a median of 3306505.19 in 2017.
• The sharpest annual moves came in 2018 and 2019: Income from Continuing Operations tumbled 37.71% in 2018, then fell 0.58% in 2019.
• A 4-year view of Income from Continuing Operations shows it stood at 2739462.19 in 2016, then dropped by 1.55% to 2781950.08 in 2017, then plunged by 37.71% to 3831060.31 in 2018, then dropped by 0.58% to 3853361.65 in 2019.
• The last three Income from Continuing Operations figures came in at 3853361.65 (Q4 2019), 3831060.31 (Q4 2018), and 2781950.08 (Q4 2017), per Business Quant data.